Back to Search
MATTHEW GOULET, M.D.
M.D.
Psychiatry Physician
NPI: 1841331550Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
172817(NY)
Research & Publications (20)
Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor.
PMID 19095769·Mol Endocrinol·2009
7-preclinical
Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success.
PMID 19523340·Cell Transplant·2009
7-preclinical
DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III.
PMID 19442771·Am J Hum Genet·2009
8-other
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
PMID 18021763·Eur J Pharmacol·2008
4-observational
Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators.
PMID 18479920·Bioorg Med Chem Lett·2008
8-other
Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC.
PMID 19075287·J Exp Med·2008
7-preclinical
Tailoring the specificity of a plant cystatin toward herbivorous insect digestive cysteine proteases by single mutations at positively selected amino acid sites.
PMID 18192440·Plant Physiol·2008
7-preclinical
Hybrid protease inhibitors for pest and pathogen control--a functional cost for the fusion partners?
PMID 18550379·Plant Physiol Biochem·2008
8-other
Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist.
PMID 18333607·J Med Chem·2008
7-preclinical
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
PMID 17327489·J Pharmacol Exp Ther·2007
7-preclinical
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
PMID 17535893·Proc Natl Acad Sci U S A·2007
7-preclinical
Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
PMID 17555869·Mol Cell Endocrinol·2007
7-preclinical
Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies.
PMID 18049116·Transplantation·2007
7-preclinical
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists.
PMID 17293109·Bioorg Med Chem Lett·2007
7-preclinical
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists.
PMID 17270441·Bioorg Med Chem Lett·2007
7-preclinical
Recognition of H-2K(b) by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function.
PMID 17240452·Mol Immunol·2007
7-preclinical
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
PMID 17608398·J Med Chem·2007
7-preclinical
Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
PMID 17235323·Mol Ther·2007
7-preclinical
First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up.
PMID 17142039·Neuromuscul Disord·2007
3-trial
Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure.
PMID 17176617·Cell Transplant·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 348 W 20TH ST
NEW YORK, NY 10011 - Phone
- (212) 529-8234
Quick Facts
- NPI
- 1841331550
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile